Acute lymphoblastic leukemia (ALL) is a type of cancer that affects the blood and bone marrow, characterized by the overproduction of immature lymphocytes. When classified as 'in remission,' it indicates that the disease is not currently active, which is crucial for treatment planning and monitoring. The ICD-10 Code C91.01 facilitates accurate diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively track patient outcomes and resource utilization.
ICD-10 Code C91.01 represents Acute lymphoblastic leukemia, in remission. This code is used when a patient has achieved remission from ALL, indicating that the signs and symptoms of the disease are no longer present. It is essential for clinical documentation and billing to reflect the patient's current status accurately, ensuring appropriate treatment plans and resource allocation.
Acute lymphoblastic leukemia, in remission, occurs when the aggressive proliferation of lymphoblasts has been controlled, leading to a significant reduction in disease symptoms. This condition requires ongoing medical supervision to monitor for potential relapse and manage any residual effects of treatment.
In SOAP notes, ICD-10 Code C91.01 is utilized to document the patient's remission status, guiding clinical assessments and treatment plans. It plays a vital role in both acute and chronic care settings, ensuring that healthcare providers have a clear understanding of the patient's current health status.
ICD-10 Code C91.01 connects subjective reports of symptoms and objective clinical findings to a formal diagnosis of remission in acute lymphoblastic leukemia. This code is crucial for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.
Management of Acute lymphoblastic leukemia, in remission, focuses on maintaining remission and preventing relapse. Treatment strategies may include ongoing chemotherapy and supportive care.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code C91.01 is essential for accurate billing in hospital, ER, or infectious disease care settings, reflecting the patient's remission status.
| CPT Code | Description |
|---|---|
| 99213 | Established patient office visit, moderate complexity. |
| 36415 | Collection of venous blood by venipuncture. |
| 85025 | Complete blood count (CBC) with automated differential. |
| 85027 | Complete blood count (CBC) with manual differential. |
Common Questions About Using ICD-10 Code C91.01 for Acute lymphoblastic leukemia, in remission
What does it mean for Acute lymphoblastic leukemia to be in remission?
Remission in Acute lymphoblastic leukemia indicates that the signs and symptoms of the disease are no longer present, and the patient is responding well to treatment. Regular monitoring is essential to ensure that the disease does not return.
How is remission determined in patients with Acute lymphoblastic leukemia?
Remission is typically determined through clinical evaluations, blood tests, and bone marrow biopsies that show no evidence of leukemic cells. Ongoing assessments are crucial to monitor for any signs of relapse.
What are the common treatments for maintaining remission in Acute lymphoblastic leukemia?
Common treatments include ongoing chemotherapy, regular follow-up appointments, and supportive care to manage any side effects. Patients may also receive psychosocial support to address emotional well-being.
How does ICD-10 Code C91.01 affect billing and insurance claims?
ICD-10 Code C91.01 is critical for accurate billing and insurance claims, as it reflects the patient's remission status. Proper documentation ensures that healthcare providers receive appropriate reimbursement for services rendered.
Clinical Notes
SOAP notes
DAP notes
AI medical notes